Related Experiment Video
Updated: Jun 12, 2026

Chromatin Immunoprecipitation (ChIP) to Assay Dynamic Histone Modification in Activated Gene Expression in Human Cells
Published on: July 29, 2010
Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP
Mary L Nelson1, Hyun-Seo Kang, Gregory M Lee
1Department of Oncological Sciences, University of Utah School of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA.
Abstract:
Ras/MAPK signaling is often aberrantly activated in human cancers. The downstream effectors are transcription factors, including those encoded by the ETS gene family. Using cell-based assays and biophysical measurements, we have determined the mechanism by which Ras/MAPK signaling affects the function of Ets1 via phosphorylation of Thr38 and Ser41. These ERK2 phosphoacceptors lie within the unstructured N-terminal region of Ets1, immediately adjacent to the PNT domain. NMR spectroscopic analyses demonstrated that the PNT domain is a four-helix bundle (H2-H5), resembling the SAM domain, appended with two additional helices (H0-H1). Phosphorylation shifted a conformational equilibrium, displacing the dynamic helix H0 from the core bundle. The affinity of Ets1 for the TAZ1 (or CH1) domain of the coactivator CBP was enhanced 34-fold by phosphorylation, and this binding was sensitive to ionic strength. NMR-monitored titration experiments mapped the interaction surfaces of the TAZ1 domain and Ets1, the latter encompassing both the phosphoacceptors and PNT domain. Charge complementarity of these surfaces indicate that electrostatic forces act in concert with a conformational equilibrium to mediate phosphorylation effects. We conclude that the dynamic helical elements of Ets1, appended to a conserved structural core, constitute a phospho-switch that directs Ras/MAPK signaling to downstream changes in gene expression. This detailed structural and mechanistic information will guide strategies for targeting ETS proteins in human disease.
Insights
Ras/MAPK pathway activation in cancer influences Ets1 protein function through phosphorylation. This structural study reveals a phospho-switch mechanism enhancing Ets1 binding to coactivators, impacting gene expression.
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- Aberrant Ras/MAPK signaling is common in human cancers.
- ETS gene family transcription factors are downstream effectors of this pathway.
Purpose of the Study:
- To elucidate the mechanism by which Ras/MAPK signaling regulates Ets1 function via phosphorylation.
- To determine the structural and biophysical basis of Ets1 regulation.
Main Methods:
- Cell-based assays
- Nuclear Magnetic Resonance (NMR) spectroscopy
- Biophysical measurements
Main Results:
- Phosphorylation of Ets1 at Thr38 and Ser41 by ERK2 alters its conformation.
- NMR revealed Ets1's PNT domain is a four-helix bundle with dynamic elements.
- Phosphorylation enhanced Ets1 affinity for the TAZ1 domain of CBP by 34-fold.
- Interaction surfaces and electrostatic forces governing binding were mapped.
Conclusions:
- Ets1 possesses a phospho-switch mechanism involving dynamic helical elements.
- This switch modulates Ets1's interaction with coactivators like CBP, affecting gene expression.
- Understanding this mechanism can inform therapeutic strategies targeting ETS proteins in disease.
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
MAPK Signaling Cascades
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway

